enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Esketamine - Wikipedia

    en.wikipedia.org/wiki/Esketamine

    [64] [65] Johnson & Johnson filed a Food and Drug Administration (FDA) New Drug Application (NDA) for approval on 4 September 2018; [67] the application was endorsed by an FDA advisory panel on 12 February 2019, and on 5 March 2019, the FDA approved esketamine, in conjunction with an oral antidepressant, for the treatment of depression in ...

  3. Velpatasvir - Wikipedia

    en.wikipedia.org/wiki/Velpatasvir

    Epclusa, Sofosvel, Velpanat (all in combination with sofosbuvir) Routes of administration: Oral : ATC code: J05AP55 ... CAS Number: 1377049-84-7; PubChem CID: 67683363;

  4. Sofosbuvir/velpatasvir - Wikipedia

    en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

    Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [ 2 ] [ 5 ] [ 6 ] [ 7 ] It combines sofosbuvir and velpatasvir .

  5. FDA Panel Nod for J&J's Esketamine Is Good News for ... - AOL

    www.aol.com/news/fda-panel-nod-j-js-170323319.html

    Esketamine is the molecular mirror image of the sedative ketamine, often prescribed off-label for severe cases of depression involving the risk of suicide. FDA Panel Nod for J&J's Esketamine Is ...

  6. FDA approves Johnson & Johnson’s ketamine-derived ... - AOL

    www.aol.com/finance/fda-approves-johnson-johnson...

    FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment. Beth Greenfield. January 22, 2025 at 8:28 PM ... Spravato is made from esketamine, ...

  7. FDA approves standalone use of J&J’s ketamine-derived ... - AOL

    www.aol.com/news/fda-approves-standalone-j-j...

    Esketamine, the chemical name for Spravato, is a chemical mirror image of anesthetic ketamine, which is also abused as a recreational party drug and goes by the street nickname “Special K”.

  8. XW10508 - Wikipedia

    en.wikipedia.org/wiki/XW10508

    The drug is a novel esketamine analogue and conjugate that acts as a prodrug of esketamine. [3] Esketamine, and by extension XW10508, is an NMDA receptor antagonist and indirect AMPA receptor activator. [1] [5] XW10508 is being developed as once-daily orally administered extended-release and immediate-release formulations with misuse resistance ...

  9. Ketamine - Wikipedia

    en.wikipedia.org/wiki/Ketamine

    An enantiomer of ketamine – esketamine commercially sold as Spravato – was approved as an antidepressant by the European Medicines Agency in 2019. [63] Esketamine was approved as a nasal spray for treatment-resistant depression in the United States [64] and elsewhere in 2019 (see Esketamine and Depression). The Canadian Network for Mood and ...